Stephen H. Bartelmez

Nessuna posizione attualmente

Consumer Services

Health Technology

Profilo

Stephen H.
Bartelmez is President and Chief Executive Officer of Ixion Biotechnology, Inc. He joined Ixion Biotechnology in September 2005 as a Director.
Prior to joining Ixion Biotechnology, Dr. Bartelmez was Director of Research for HemoGenix and a Faculty Member of the University of Washington.
Previously, he held various positions at ViaCell, Inc. Dr. Bartelmez received a BS degree from the University of California and a PhD from the University of Glasgow.

Precedenti posizioni note di Stephen H. Bartelmez

Società	Posizione	Fine
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	Corporate Officer/Principal	-
ViaCell, Inc. ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
Ixion Biotechnology, Inc. Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Stephen H. Bartelmez

Formazione di Stephen H. Bartelmez

University of Glasgow	Doctorate Degree
University of California, Berkeley	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private